Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MadeMed vs Enhance MD

MadeMed
Graded #29

Lower grade

vs+4.3999999999999915
Enhance MD
Graded #13

Higher grade

The verdict

Enhance MD takes it — 84.8/100 to 80.4/100.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.

We may earn a commission if you start care through some of these links, at no extra cost to you. Affiliate partners are listed first — a capped 3-point edge in board order only. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEnhance MD +8
74
82
Dose & formulationMadeMed +8
90
82
Clinical oversightEnhance MD +4
84
88
Labs & monitoringEnhance MD +28
62
90
FulfillmentMadeMed +6
90
84
Contract termsMadeMed +4
88
84
MadeMed · left barEnhance MD · right bar

The numbers

MetricMadeMedEnhance MD
WeighScore80.4/10084.8/100
GradeB−B
Scorecard rank#29#13
Semaglutide$239/mo quarterly (from $199/mo on 6 months)$212/mo
Tirzepatide$399/mo quarterly (from $369/mo on 6 months)$280/mo
Coverage40 statesNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
MadeMed

Graded #29 · B−

Strengths

  • One flat price at every dose, published dose by dose — semaglutide 0.25–2.4mg, tirzepatide 2.5–15mg
  • LegitScript verified, with board-certified physician review and US compounding pharmacies
  • Full refund minus a $39 visit fee if you are not prescribed, stated before checkout
  • Oral semaglutide and oral tirzepatide alongside the injections; free overnight shipping with supplies

Where it loses points

  • The most expensive tirzepatide here at $399/mo quarterly
  • 40 states rather than nationwide
  • No published recurring lab programme
  • Ships one vial every two months, a less flexible cadence than a monthly refill
Enhance MD

Graded #13 · B

Strengths

  • Transparent tiered pricing across sema, tirz, microdose, and combo
  • Dose-flat — the price does not step up as you titrate
  • Six-month lab testing plus provider-led care
  • NAD+ longevity adjacency available

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • No oral or sublingual route
  • States served are not published
  • Higher entry price than the cheapest compounded programs

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 43 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard